Cargando…

Technical aspects of amyloid imaging for Alzheimer's disease

[(11)C]Pittsburgh Compound B positron emission tomography has now been extensively used to evaluate the amyloid load in different types of dementia and has become a powerful research tool in the field of neurodegenerative diseases. In the present short review we discuss the properties of amyloid ima...

Descripción completa

Detalles Bibliográficos
Autores principales: Edison, Paul, Hinz, Rainer, Brooks, David J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226280/
https://www.ncbi.nlm.nih.gov/pubmed/21888692
http://dx.doi.org/10.1186/alzrt87
_version_ 1782217592917721088
author Edison, Paul
Hinz, Rainer
Brooks, David J
author_facet Edison, Paul
Hinz, Rainer
Brooks, David J
author_sort Edison, Paul
collection PubMed
description [(11)C]Pittsburgh Compound B positron emission tomography has now been extensively used to evaluate the amyloid load in different types of dementia and has become a powerful research tool in the field of neurodegenerative diseases. In the present short review we discuss the properties of amyloid imaging agent [(11)C]Pittsburgh Compound B, the different modalities of molecular imaging, image processing and data analysis, and newer amyloid imaging agents.
format Online
Article
Text
id pubmed-3226280
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32262802012-03-02 Technical aspects of amyloid imaging for Alzheimer's disease Edison, Paul Hinz, Rainer Brooks, David J Alzheimers Res Ther Review [(11)C]Pittsburgh Compound B positron emission tomography has now been extensively used to evaluate the amyloid load in different types of dementia and has become a powerful research tool in the field of neurodegenerative diseases. In the present short review we discuss the properties of amyloid imaging agent [(11)C]Pittsburgh Compound B, the different modalities of molecular imaging, image processing and data analysis, and newer amyloid imaging agents. BioMed Central 2011-08-31 /pmc/articles/PMC3226280/ /pubmed/21888692 http://dx.doi.org/10.1186/alzrt87 Text en Copyright ©2011 BioMed Central Ltd
spellingShingle Review
Edison, Paul
Hinz, Rainer
Brooks, David J
Technical aspects of amyloid imaging for Alzheimer's disease
title Technical aspects of amyloid imaging for Alzheimer's disease
title_full Technical aspects of amyloid imaging for Alzheimer's disease
title_fullStr Technical aspects of amyloid imaging for Alzheimer's disease
title_full_unstemmed Technical aspects of amyloid imaging for Alzheimer's disease
title_short Technical aspects of amyloid imaging for Alzheimer's disease
title_sort technical aspects of amyloid imaging for alzheimer's disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226280/
https://www.ncbi.nlm.nih.gov/pubmed/21888692
http://dx.doi.org/10.1186/alzrt87
work_keys_str_mv AT edisonpaul technicalaspectsofamyloidimagingforalzheimersdisease
AT hinzrainer technicalaspectsofamyloidimagingforalzheimersdisease
AT brooksdavidj technicalaspectsofamyloidimagingforalzheimersdisease